Skip to main content
Premium Trial:

Request an Annual Quote

We Never Guessed that Genomics Would Become a Recreational Activity

An editorial in the European Journal of Human Genetics from GertJan van Ommen at the Leiden University Medical Center and Martina Cornel at VU University Medical Centre in Amsterdam looks at the concept of "recreational genomics" and recent advances in screening tools for genetic susceptibility to disease. "Has science progressed in a never precedented way," the writers ask, "or are we witnessing a hype of naive and commercial hopes and beliefs?" They conclude that "the European lack of progress" toward market-oriented healthcare "may become our strength indeed" as innovations in genomics make a stronger case for universal coverage.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.